Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.

Current drug targets. Immune, endocrine and metabolic disorders

Volumn 3, Issue 4, 2003, Pages 255-262

  Masuzaki, Hiroaki ^a   Flier, Jeffrey S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID;

ADIPOSE TISSUE; ANIMAL; ANTIBODY SPECIFICITY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLIC SYNDROME X; METABOLISM; METHODOLOGY; REVIEW; SKELETAL MUSCLE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ANIMALS; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; METABOLIC SYNDROME X; MUSCLE, SKELETAL; ORGAN SPECIFICITY;

EID: 1542675142     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568008033340135     Document Type: Review

References (58)